Differentiation of Dry Mouth Etiology

1996 ◽  
Vol 10 (1) ◽  
pp. 13-16 ◽  
Author(s):  
P.C. Fox
Keyword(s):  
Salivary Gland ◽  
Dry Mouth ◽  
Common Complaint ◽  
Oral Dryness ◽  
Salivary Gland Disease

Dry mouth is a common complaint. While it is often considered to be synonymous with the diagnosis of salivary gland disease, this is not the case. There are many causes of the symptomatic complaint of oral dryness, both salivary and non-salivary. This paper will review the causes of "dry mouth" and the means of establishing the underlying diagnosis.

Sonoelastographic modalities in the evaluation of salivary gland disease

2016 ◽  
Vol 37 (S 01) ◽  
Author(s):  
B Hofauer ◽  
N Mansour ◽  
M Bas ◽  
K Stock ◽  
A Knopf
Keyword(s):  
Salivary Gland ◽  
Salivary Gland Disease

Ultrasonography in salivary gland disease

1984 ◽  
Vol 20 (4) ◽  
pp. 795 ◽  
Author(s):  
E Y Kang ◽  
S J Cha ◽  
S H Cha ◽  
H Y Seol ◽  
K B Chung ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Salivary Gland Disease

Immunologic Approaches to the Therapy of Autoimmune Salivary Gland Disease

1987 ◽  
Vol 66 (2_suppl) ◽  
pp. 703-708
Author(s):  
H.C. Lane ◽  
A.S. Fauci
Keyword(s):  
Salivary Gland ◽  
B Lymphocytes ◽  
Cell Function ◽  
Immunosuppressive Agents ◽  
Therapeutic Strategies ◽  
Treatment Regimens ◽  
Theoretical Approaches ◽  
Biologic Response ◽  
Benign Nature ◽  
Salivary Gland Disease

A variety of immunologic mechanisms may theoretically give rise to disease in the salivary glands. Among them are abnormal antibody production, hyper-reactive T-lymphocytes, and mono- or oligoclonal expansions of B-lymphocytes, While it is not clear which, if any, of these mechanisms are of prime importance in the immunopathology of salivary gland disease, they provide a framework, within which to discuss theoretical approaches to the treatment of autoimmune salivary gland disease. Among the techniques used to decrease antibody-induced damage are non-steroidal anti-inflammatory agents, plasmapheresis, and corticosteroids. Cyclosporin, monoclonal antibodies, and biologic response-modifiers may be used to modulate T-cell function, and anti-idiotype antibodies or immunosuppressive agents may be used to treat malignant expansions of B-cells. Although the generally benign nature of autoimmune salivary gland disease precludes the use of many of the potentially toxic treatment regimens discussed here, the appreciation of these approaches to immunomodulation provides a basis upon which to develop new and innovative therapeutic strategies.

HIV-associated salivary gland disease: literature review and report of three cases

1997 ◽  
Vol 35 (3) ◽  
pp. 218
Author(s):  
A. Schmidt-Westhausen ◽  
H.D. Pohle ◽  
H. Lobeck ◽  
P.A. Reichart
Keyword(s):  
Salivary Gland ◽  
Literature Review ◽  
Salivary Gland Disease

scholarly journals Xerostomia and its Dental Implications: A Review

2013 ◽  
Vol 7 (3) ◽  
pp. 166-169 ◽  
Author(s):  
V Madhumathi ◽  
R Swamy
Keyword(s):  
Oral Health ◽  
Dental Care ◽  
Dry Mouth ◽  
Pharmacological Agents ◽  
Oral Function ◽  
Aged Population ◽  
Common Complaint

ABSTRACT Xerostomia is a relatively common complaint often related to the use of certain pharmacological agents. Knowledge about xerostomia, its effect on oral health among the aged population and provision of modified dental care for these patients are the objectives of this review. Further explaining the methods to improve the comfort and oral function of dentate and edentate patients with dry mouth.

scholarly journals Botulinum Toxin Type A Injection as a Treatment of Salivary Gland Disease

2014 ◽  
Vol 25 (2) ◽  
pp. 142-149
Author(s):  
Yoon-Ju Lee ◽  
Sung-Chan Shin ◽  
Won-Jae Cha ◽  
Byung-Joo Lee ◽  
Soo-Geun Wang
Keyword(s):  
Salivary Gland ◽  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Salivary Gland Disease
Sign in / Sign up

Export Citation Format

Share Document